Objective Chemoreflex hypersensitity was caused by obstructive sleep apnea (OSA) in
patients with metabolic syndrome (MetS). This study tested the hypothesis that hypocaloric …

The prevalence of sleep disordered breathing (SDB) is reportedly very high. Among SDBs,
the incidence of obstructive sleep apnea (OSA) is higher than previously believed, with …

Obstructive sleep apnoea (OSA) is a common disorder that is associated with serious
comorbidities with a negative impact on quality of life, life expectancy and health costs. As …

Sleep disordered breathing (SDB) is a leading cause of morbidity worldwide. Its prevalence
increases with age. Due to the demographic changes in industrial societies, pulmonologists …

Leptin is an adipokine directly correlated with the proinflammatory obese-associated
phenotype. Leptin has been demonstrated to inhibit adipogenesis, promote fat demarcation …

Health, according to the World Health Organization, is conceptualized not as only the
absence of disease but also as full human physical, emotional, mental, and social function. 1 …

Background Although recent evidence suggests that OSA treatment may cause weight gain,
the long-term effects of CPAP on weight are not well established. Methods This study was a …

Study Objectives: To determine whether an intensive weight-loss program (IWLP) is effective
for reducing weight, the severity of obstructive sleep apnea (OSA), and metabolic variables …

Aim Although pedometer intervention is effective in increasing physical activity among adults
with Type 2 diabetes, its impact on weight loss remains unclear. This meta‐analysis was …

Objectives This analysis characterized changes in weight in participants with obstructive
sleep apnea (OSA) or narcolepsy treated with solriamfetol (Sunosi™) 37.5 (OSA only), 75 …